Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Akums Drugs and Pharmaceutical
AKUMS | NSE
483.00
INR15.80
3.38%
AKUMS | NSE
About Akums Drugs and Pharmaceutical
Sector
IN
Industry
IN
Earnings date
01/01/1970
As of date
05/03/2026
Close
483.00
Open
468.10
High
489.00
Low
468.10
View Less
AKUMS | NSE
Risk
35.5
Sharpe
-0.25
Luna's Score
51/100
Recommendation
Hold
Luna says (AKUMS | NSE)
What's Working
Positive Momentum
Low 6-Month Volatility (<30%)
What's not Working
High Short-term Volatility
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
30.3%1 month
35.5%3 months
26.4%6 months
26.1%Returns
Fundamental Ratios
PE
10.40K
Fwd. PE
-
Price to book
18.53
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
102.76
Ent. to rev.
3.34
PEG
-
Other Fundamentals
EBITDA
4.96B
MarketCap
69.48B
MarketCap(USD)
756.02M
Div. yield
-
Op. margin
8.84
Erngs. growth
-
Rev. growth
5.10
Ret. on equity
-
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
45.90
Range1M
66.00
Range3M
96.70
Volumes: Market Activity
Rel. volume
0.33
Price X volume
51.31M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 102.76 | 38.27 | Expensive |
| Ent. to Revenue | 3.34 | 10.34 | Cheaper |
| PE Ratio | 10,396.90 | 60.68 | Expensive |
| Price to Book | 18.53 | 9.15 | Expensive |
| Dividend Yield | - | 0.66 | - |
| Std. Deviation (3M) | 26.40 | 43.73 | Lower Risk |
| Debt to Equity | - | 0.59 | - |
| Debt to Assets | - | 0.20 | - |
| Market Cap | 69.48B | 104.65B | Emerging |
